Topics covered: Valuations, The new product pipeline, Stock picks, Scientific trends, Partnership in pharma, Offsetting development costs, Impact of the FDA, Growth Prospects, Biotech Sector Outlook, Big pharma in biotech, Balancing the risk spectrum, Appreciation of the biotech space
